New research confirms that end-stage renal disease is a significant risk factor for patients undergoing cataract surgery. Patients with end-stage renal disease (ESRD) face a higher risk of vitreous ...
Investigators analyzed retinal hemorrhages and macular edema events in patients treated with roxadustat or darbepoetin alfa. The risk of developing ophthalmic abnormalities appears no higher with ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today presented positive results from the Phase IIIb DIALIZE trial which investigated the efficacy and safety of LOKELMA (sodium zirconium cyclosilicate) ...
A 47-year-old man with end-stage renal disease (ESRD), type 2 diabetes mellitus, hypertension, and coronary artery disease was started on peritoneal dialysis (PD) 2 years prior after a renal allograft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback